Skip to content
value.today

Samil Pharmaceutical Co., Ltd

000520.KS
$86 Mlast known market cap, Jan 2024 — no current value
Compare
World rank
—
no current market cap
Revenue
—
annual
Net income
—
Employees
—

Samil Pharmaceutical Co., Ltd in brief

Samil Pharmaceutical Co., Ltd is a listed company in the Pharmaceutical industry, based in South Korea. Its last known market value was $86 M (January 2024); there is no current figure. Its shares trade under the symbol 000520.KS (South Korea).

Written from the figures on this page, so it changes when they do. Dates and sources are under Sources and freshness.

Market cap history

$0 M$32 M$64 M$96 M$129 M20202021202220232024

World rank over time

▼ down 3,731 places since 2020
2020-01-01: #18435#18,43520202021-01-01: #17551#17,55120212022-01-07: #23475#23,47520222022-12-25: #22823#22,82320222023-07-30: #22862#22,86220232024-01-05: #22166#22,1662024

Rank in South Korea: #516 (Jan 2020) · #536 (Jan 2021) · #643 (Jan 2022) · #900 (Dec 2022) · #940 (Jul 2023) · #916 (Jan 2024)

Mutual funds holding Samil Pharmaceutical Co., Ltd#

10 funds hold shares worth $1 M. Since their previous reports 0 added shares and 2 sold, selling $0 M net.
Mutual funds holding Samil Pharmaceutical Co., Ltd
FundSharesValueOf the companyOf the fundChange in sharesReport
🇺🇸 Emerging Markets Core Equity 2 PortfolioDimensional Fund Advisors LP81,400$0 M—<0.01%no changeJul 31, 2026
🇺🇸 Dimensional Emerging Markets Core Equity 2 ETFDimensional Fund Advisors LP22,008$0 M—<0.01%no changeJul 31, 2026
🇺🇸 Dimensional Emerging Core Equity Market ETFDimensional Fund Advisors LP18,044$0 M—<0.01%no changeJul 31, 2026
🇺🇸 Dimensional World ex. U.S. Core Equity 2 ETFDimensional Fund Advisors LP12,433$0 M—<0.01%no changeJul 31, 2026
🇺🇸 Emerging Markets Social Core Equity PortfolioDimensional Fund Advisors LP3,172$0 M—<0.01%no changeJul 31, 2026
🇺🇸 World ex U.S. Core Equity PortfolioDimensional Fund Advisors LP2,975$0 M—<0.01%no changeJul 31, 2026
🇺🇸 Emerging Markets Sustainability Core 1 PortfolioDimensional Fund Advisors LP2,871$0 M—<0.01%no changeJul 31, 2026
🇺🇸 The Emerging Markets Small Cap SeriesDimensional Fund Advisors LP1,687$0 M—<0.01%−95%Jul 31, 2026
🇺🇸 Dimensional Emerging Markets Sustainability Core 1 ETFDimensional Fund Advisors LP538$0 M—<0.01%no changeJul 31, 2026
🇺🇸 Dimensional Emerging Markets ex China Core Equity ETFDimensional Fund Advisors LP28$0 M—<0.01%no changeJul 31, 2026

Source: Fund portfolio reports to the SEC (Form N-PORT), CVM, Finansinspektionen and Indian fund houses · as of Jul 31, 2026. The 10 largest positions, each from the fund's newest report; report dates differ between funds. A fund family's funds are listed one by one, so one manager can appear many times.

Peer comparison · Pharmaceutical

CompanyMarket capP/ENet marginRev. growth
Samil Pharmaceutical Co., Ltd🇰🇷$86 M———
Eli Lilly and Company🇺🇸$1.20 T43.4×31.9%+44.7%
Johnson & Johnson🇺🇸$652.5 B40.5×16.2%+6.0%
AbbVie Inc.🇺🇸$514.0 B49.7×15.7%+8.6%
Roche Holding AG🇨🇭$370.3 B29.1×19.0%—
Merck & Co., Inc.🇺🇸$359.8 B146.7×3.6%+1.3%
Novartis AG🇨🇭$286.8 B20.5×24.7%—
Amgen Inc.🇺🇸$249.2 B26.5×24.1%+9.9%
AstraZeneca PLC🇬🇧$242.6 B23.7×17.4%+8.6%

P/E and margins use trailing 12-month results where available; growth is the latest fiscal year.

Questions, comparisons and similar companies#

Sources and freshness

Market cap:
Jan 5, 2024 (last known)
Profile updated:
Nov 15, 2026

Figures from value.today research.

How each figure is collected: data sources and methodology. Market caps in US dollars unless you switch the currency.

Work at Samil Pharmaceutical Co., Ltd? Verify and update this profile — free

Use your work e-mail address (on the company's own domain if possible). Fill in only what is new or missing; a link to where the figures are published (annual report, press release) speeds up the review.

Show Samil Pharmaceutical Co., Ltd's ranking on your website Get the badge
Badge preview

The badge updates itself as the ranking changes.

Something wrong or missing about Samil Pharmaceutical Co., Ltd? Suggest a correction